CTLA4 and cancer: The CTLA-4 -1722T/C polymorphism (T→C) would reduce a transcription factor binding site for nuclear factor 1 and weaken the expression of cell surface CTLA-4 [11], [25], which might play an important role in cancer and autoimmune disease susceptibility.